follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsAnkit Singhania

      Articles by Ankit Singhania

      Ankit Singhania
      Based in India, Ankit is a financial content writer and stock market analyst. He has worked for almost a decade on several financial projects related to the stock market news, fundamental research and technical analysis for several websites. He obtained his Masters Degree In finance (MS – finance) from ICFAI. Currently, he serves as a financial consultant and technical analyst at Tradersinsights.com.
      CODX stock
      Medical

      CODX Stock Extends Rally, Rockets 445% This Week

      Feb 27 Ankit Singhania
      Fresh panic has surfaced with regards to the coronavirus this week after the virus spread to more countries outside of China. The movement has affected certain stocks, one of which has been Co-Diagnostics (NASDAQ:CODX), with ... [Read]
      CHK stock
      Oil & Gas

      CHK Stock Hits a New Low After Disappointing Quarterly Earnings

      Feb 26 Ankit Singhania
      CHK stock is under pressure on Wednesday after offshore exploration company Chesapeake Energy Corporation (NYSE:CHK) reported its fourth-quarter results. The company’s losses in the quarter were actually lower than what had been expected, but even ... [Read]
      Moneygram stock
      Credit Services

      MoneyGram Stock Falls Despite Better Q4 Results on Ripple’s Investment

      Feb 25 Ankit Singhania
      Moneygram stock is trading lower this morning despite MoneyGram International Inc (NASDAQ:MGI) reporting a better-than-expected Q4 financial report. Over the past few years, blockchain company Ripple has signed a range of important partnerships, and one ... [Read]
      ENLV stock
      Biotechnology

      ENLV Stock Gains 45% as Company is Set to Raise Capacity for Allocetra

      Feb 24 Ankit Singhania
      Enlivex Therapeutics Ltd (NASDAQ:ENLV), a clinical-stage immunotherapy firm based out of Israel, announced today that it is going to raise the manufacturing capacity of its product Allocetra. What kind of effect will this have on ... [Read]
      DPW stock
      Industrial Products

      DPW Stock Rallies After Getting $1.4 Million Follow-Up Order

      Feb 21 Ankit Singhania
      DPW stock is on a roll this morning after DPW Holdings (NYSE:DPW) announced that it has received a substantial follow-up order from one of its clients. This morning, the company announced that a well-known defense ... [Read]
      BBI stock
      Biotechnology

      BBI Stock Doubles After Positive Data for Sofpironium Bromide

      Feb 20 Ankit Singhania
      In a fresh development that has come as a big boost BBI stock, Brickell Biotech Inc (NASDAQ:BBI) released positive results from the Phase 2b clinical trial of one of its products. The product in question ... [Read]
      PLUG stock
      Industrial Products

      PLUG Stock Hits New 52-Week High, Rockets 60% in 2020

      Feb 19 Ankit Singhania
      Fuel cell solutions company Plug Power Inc (NASDAQ:PLUG) has seen its stock rising steadily for much of the year so far and has emerged as one of the stocks that could be tracked by investors. ... [Read]
      MITO stock
      Biotechnology

      MITO Stock Soars on Impressive Elamipretide Data

      Feb 18 Ankit Singhania
      Stealth BioTherapeutics Corp (NASDAQ:MITO) made a major announcement today regarding elamipretide, which resulted in a highly impressive rally in MITO stock this morning. A natural history study of elamipretide has revealed that subcutaneous injections of ... [Read]
      GNPX stock
      Biotechnology

      GNPX Stock is Up 900% in a Month, But Why the Sudden Growth?

      Feb 14 Ankit Singhania
      Over the past month, thinly traded penny stock Genprex Inc (NASDAQ:GNPX) has managed to come into sharp focus in the market. GNPX stock has rallied by as much as 900% during the period and has ... [Read]
      BE stock
      Industrial Products

      BE Stock Slumps 10% After Discovering Accounting Error

      Feb 13 Ankit Singhania
      In a development that has come as a major blow to BE stock, Bloom Energy Corp (NYSE:BE) announced late Wednesday that there has been a major accounting error in its records. This means that all ... [Read]

      Posts pagination

      « 1 … 5 6 7 … 27 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE Co-Diagnostics Email Alerts
      Get FREE Co-Diagnostics Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x